Related Experiment Video
Updated: Aug 15, 2026

07:24
Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing
Published on: February 10, 2023
Phosphoglucomutase polymorphism detected by isoelectric focusing: gene frequencies, evolution and linkage
Annals of Human Biology
|May 1, 1979
Summary
Genetic analysis reveals four phosphoglucomutase (PGM1) alleles in humans, with varying frequencies across populations. Linkage analysis shows weak PGM1-Rhesus linkage in males, and primate studies suggest a common PGM1+1 ancestral locus.
Area of Science:
- Human genetics
- Population genetics
- Molecular evolution
Background:
- The phosphoglucomutase (PGM1) enzyme plays a crucial role in carbohydrate metabolism.
- Isoelectric focusing has recently identified four distinct alleles at the human PGM1 locus.
Purpose of the Study:
- To estimate gene frequencies for the four PGM1 alleles in different human populations.
- To investigate potential genetic linkage between the PGM1 and rhesus loci.
- To explore the evolutionary origins of PGM1 alleles by examining primate phenotypes.
Main Methods:
- Isoelectric focusing for PGM1 phenotyping.
- Gene frequency estimation in four distinct populations.
- Pedigree analysis for linkage studies.
- Comparative analysis of PGM1 phenotypes across primate species.
Main Results:
- Significant differences in PGM1 allele frequencies were observed among the studied populations.
- Weak genetic linkage was detected between the PGM1 and rhesus loci in males, but not in females.
- Several primate species exhibit PGM1 phenotypes similar to the human PGM1+1 allele.
Conclusions:
- The findings suggest population-specific variations in PGM1 allele frequencies.
- The PGM1 and rhesus loci exhibit sex-specific linkage patterns.
- Evidence supports the hypothesis of a common ancestral PGM1+1 locus for both human and primate alleles, indicating conserved evolutionary history.
Related Concept Videos
Gene Evolution - Fast or Slow?
The genomes of eukaryotes are punctuated by long stretches of sequence which do not code for proteins or RNAs. Although some of these regions do contain crucial regulatory sequences, the vast majority of this DNA serves no known function. Typically, these regions of the genome are the ones in which the fastest change, in evolutionary terms, is observed, because there is typically little to no selection pressure acting on these regions to preserve their sequences.
In contrast, regions which code...
In contrast, regions which code...
Incomplete Dominance
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
Gene Duplication and Divergence
The seminal work of Ohno in 1970 popularized the idea of gene duplication and divergence. DNA sequence comparison studies reveal that a large portion of the genes in bacteria, archaebacteria, and eukaryotes was generated by gene duplication and divergence, indicating its critical role in evolution.
The duplicated copies of the gene are called Paralogs. Paralogs with similar sequences and functions form a gene family. Across several species, a large number of gene families are characterized.
The duplicated copies of the gene are called Paralogs. Paralogs with similar sequences and functions form a gene family. Across several species, a large number of gene families are characterized.
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

